James J Loughlin insider trades: Celgene (CELG) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
and 1 more company
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 7, 2019 | CELG | ↓ Sell | 23,466 | $87.29 | $2.0M | Direct | Feb 11, 2019 (4d) |
| Jun 4, 2018 | CELG | ↓ Sell | 17,750 | $78.96 | $1.4M | Direct | Jun 5, 2018 (1d) |
| Mar 12, 2018 | CELG | ↓ Sell | 9,250 | $92.01 | $851K | Direct | Mar 13, 2018 (1d) |
| Jun 26, 2017 | CELG | ↓ Sell10b5-1 | 9,250 | $133.57 | $1.2M | Direct | Jun 27, 2017 (1d) |
| May 1, 2017 | CELG | ↓ Sell | 9,250 | $124.00 | $1.1M | Direct | May 2, 2017 (1d) |
| Mar 6, 2017 | EDGE | ↑ Buy | 3,000 | $9.24 | $28K | Family Trust | Mar 7, 2017 (1d) |
| Aug 23, 2016 | CELG | ↓ Sell | 27,500 | $114.10 | $3.1M | Direct | Aug 24, 2016 (1d) |
| Mar 21, 2016 | NSPR | ↑ Buy | 50,000 | $0.59 | $30K | Direct | Mar 23, 2016 (2d) |
| Mar 11, 2016 | EDGE | ↑ Buy | 3,000 | $7.63 | $23K | Family Trust | Mar 15, 2016 (4d) |
| Feb 22, 2016 | CELG | ↓ Sell | 2,100 | $104.12 | $219K | Direct | Feb 24, 2016 (2d) |
| Oct 6, 2015 | EDGE | ↑ Buy | 7,000 | $11.00 | $77K | Direct | Oct 8, 2015 (2d) |
| Aug 22, 2014 | CELG | ↓ Sell | 20,000 | $91.25 | $1.8M | Direct | Aug 26, 2014 (4d) |
| Apr 16, 2013 | NSPR | ↑ Buy | 15,000 | $2.00 | $30K | Direct | Apr 17, 2013 (1d) |
| Jun 22, 2012 | CELG | ↑ Buy | 600 | $60.29 | $36K | Direct | Jun 22, 2012 (0d) |
| May 6, 2009 | CELG | ↑ Buy | 600 | $39.57 | $24K | Direct | May 7, 2009 (1d) |
| Jul 25, 2006 | ACEL | ↑ Buy | 7,500 | $2.04 | $15K | Direct | Jul 26, 2006 (1d) |
| May 19, 2005 | DSCP | ↑ Buy | 1,000 | $29.80 | $30K | Direct | May 20, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James J Loughlin's insider trades
James J Loughlin is an insider at Celgene (CELG). Since May 19, 2005, James has reported 9 open-market purchases worth $292K and 8 sales worth $11.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (10% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (38 filings), option exercises (24 filings), other transactions (4 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CELG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.